The propensity of Staphylococcus aureus to cause acute endovascular infections during transient bacteremia is poorly understood. To examine the events leading to the attachment ofstaphylococci to endothelium, adherence assays were developed to study the role of blood factors in the mediation of staphylococcal adherence to cultured human umbilical vein endothelium in vitro. Results indicate that the preferential attachment of S. aureus to endothelial cells is mediated by fibrinogen adsorbed from plasma onto the endothelial surface. The binding is apparently specific because it could be blocked by goat anti-human fibrinogen antibody in a dose-dependent fashion while nonimmune goat IgG, mouse MAb against AG-i (a platelet antigen found on the endothelial cell surface), nonspecific mouse MAb and rabbit antibodies to human vitronectin and fibronectin were not inhibitory. Our data also indicate that fibrinogen is a necessary but not the only blood constituent in the mediation of binding of S. aureus to endothelium. This was supported by the finding that fibrinogen alone, at a concentration equivalent to that in plasma, did not potentiate staphylococcal adherence as much as plasma while afibrinogenemic plasma reconstituted with fibrinogen did. Because fibrinogen is known to bind to endothelial cells, our data is consistent with the hypothesis that fibrinogen and additional plasma factor(s), possibly activated during inflammation, promote staphylococcal adherence to endothelium. In addition, the role of the fibrinogen binding receptor of S. aureus as an adherence factor to native endothelium is also suggested. (J. Clin. Invest. 1991. 87:2236-2245
Introduction
Staphylococcus aureus continues to predominate as one of the most frequently encountered pathogens in nosocomial bacteremia (1, 2) . In particular, S. aureus accounts for one-quarter to one-third ofthe episodes ofbacteremia associated with intravascular devices (3) . One intriguing aspect of the pathogenesis of S. aureus bacteremic infections in a human host is the unique ability of the organism to adhere to and colonize the endothe-Receivedfor publication 4 June 1990 and in revisedform 25 January 1991. lium (4) during transient bacteremia (5, 6) . In the case ofcatheter-related bacteremia, the prevailing view is that bacterial colonization starts at the skin-catheter junction, advances down the fibrin-coated external surface of the device (7) and ultimately seeds the bloodstream (2) . Once the bacteria are in the bloodstream, patients are at an increased risk ofdeveloping endocarditis (8, 9) , especially those with underlying valvular heart diseases (congenital or rheumatic causes).
Acute infective endocarditis is a fulminant, life threatening disease of the endocardium frequently caused by S. aureus. In distinction to subacute endocarditis that commonly runs an indolent course, acute endocarditis can result in the rapid destruction of the infected valves and a high mortality (10, 11) . Furthermore, patients who are at risk of acquiring this infection usually do not have underlying valvular abnormalities.
The propensity of S. aureus to cause acute bacteremic endocarditis is poorly understood. Nonetheless, one can speculate that the bacterium must attach to the surface of the endothelium bafore invasion can occur. However, the molecular events that characterize the nonspecific and specific interactions between bacterial surface constituents and the endothelium are poorly defined. These interactions are further complicated by the fact that the endothelium can adsorb blood macromolecules onto its surface through both nonspecific (12) and specific mechanisms (13) (14) (15) . The adsorbed molecules, in turn, may serve as specific receptors for the adherence of S. aureus.
Several factors are known to potentiate interactions between endothelial cells (EC)' and the blood constituents that may serve as adhesion molecules for the underlying matrix. In particular, recent work has defined several receptors on the endothelium that are capable of recognizing an RGD (ArgGly-Asp) sequence in adhesion macromolecules (13, 14) such as fibrinogen, fibronectin, and vitronectin. Because S. aureus is known to have receptors for fibrinogen (16, 17) , fibronectin (18) (19) (20) , and vitronectin (21) , it is conceivable that these bound adhesion molecules may serve as receptors for the adherence of microorganisms to endothelium. To investigate this possibility, we examined the role ofblood factors in mediating staphylococcal adherence to cultured human umbilical vein EC in vitro. Our results indicate that fibrinogen may act as a bridging molecule in the mediation of S. aureus to cultured endothelium. Further, this study also implicates the fibrinogen binding receptor of S. aureus as an important adherence factor in the pathogenesis of endovascular invasion during staphylococcal bacteremia.
Methods
Bacterial strains. Two recent S. aureus human blood isolates, strain DB and LM, were from the Rockefeller University culture collection.
Our previous studies (22) have demonstrated the relative deficiency of protein A in strain LM as confirmed by a lack of reactivity of the cell wall antigens ofthis strain against chicken anti-protein A antibody on immunoblots. Because ofthis property, strain LM is useful in the examination of the role of blood proteins in mediating protein A-independent adhesion (22) . A S. epidermidis control, strain 6937, which has been implicated in catheter-related infections was a gift from Dennis Maki at the University of Wisconsin Medical School. All strains were stored at -70'C in chemically defined medium (CDM) (23) CFU/ml for an OD of 1.0 at 650 nm) were obtained by serial tube dilution with subsequent plating on blood agar plates. The usual specific activities were -1,000 cpm/2 X 106 for S. aureus strains and 1,000 cpm/1.5 X 106 for S. epidermidis. Preliminary experiments also revealed > 95% of the radioactivity ofthe cell suspension to be cell-associated.
Endothelial cell tissue culture. EC from human umbilical cords were obtained and cultured as previously described (24, 25) . In most studies, EC were grown to confluence on gelatin-coated 96-well microtiter plates (Coming Glass Works, Coming, NY) in the absence of antibiotics in M199 supplemented with 16% FCS, 4% human serum, endothelial cell growth factor, and heparin as described (24, 25) . In some studies, monolayers were grown on 20 X 20 mm coverslip or six well tissue culture dishes (Coming Glass Works) in the absence ofantibiotics. All experiments reported here were carried out with human EC in the second or third passage.
Assayfor adherence to endothelial cells. Unless otherwise stated, all reagents and incubations were at 37°C. To enumerate the number of endothelial cells in each well, two wells from each microtiter plate were treated with 200 Ml of 0.05% collagenase, 0.01% EDTA for 5 min followed by counting in a hemacytometer after testing for trypan blue exclusion for cell viability. In preparing cells for the adherence assays, confluent human EC monolayers in microtiter wells were washed once with 200 Ml of M 199 and then lightly fixed with 0.05% glutaraldehyde in M 199 for 5 min followed by two washes with M 199 (150 Ml each). In addition to removing glutaraldehyde from EC, washes with M199 which contains glycine and other amino acids served to quench the binding capacity ofresidual glutaraldehyde that may be present on EC. The concentration of glutaraldehyde that was used for fixation has been determined in pilot studies to be the minimal amount necessary. Preliminary studies also revealed that glutaraldehyde-treated EC were able to bind to bacterial cells approaching 50-75% of nontreated controls while retaining adherent characteristics similar to that of nonfixed endothelium (data not shown). Glutaraldehyde fixed cells have the advantage of minimizing endothelial detachment in the adherence assays during the ensuing lengthy washing procedure. Because of these properties, most ofthe adherent assays were performed with fixed cells.
For the adherence assays, wells containing glutaraldehyde-fixed EC were preincubated with either 100 Ml of M199 or heparinized plasma diluted with an equal volume of M199 (100 U of heparin in 10 ml of whole blood) at 37°C for 30 min with agitation (200 rpm) followed by two (26) without any contamination with fibronectin and vitronectin as determined by both Coomassie blue and silver stain criteria. To evaluate the effect of fibrin degradation products in serum on bacterial adherence, Staphylococcal Adherence to Endothelial Cells 2237 EC were also preincubated with treated serum devoid offibrin degradation products. The treated serum was prepared by incubating serum sample with latex particles coated with affinity purified anti-human fibrinogen fiagments D and E (Wellcome Diagnostics, Research Triangle' NC) in a 10 X 15-mm column overnight at 4VC with rotation. The absence of fibrin degradation products in the fall through was verified by a dot blot assay in which 25 gl ofthe treated serum samples together with controls (untreated serum and plasma) were allowed to react with affinity purified goat anti-human fibrinogen antibody (see below for method of preparation) followed by development with substrate (27) . In other experiments, the microtiter wells were incubated with 100 M1 of various concentrations of fibrinogen (2.5-0.1 mg/ml) in the presence of HSA (1 mg/ml) after fixation with glutaraldehyde. Several blood factors in combination were also tested to evaluate for the promotion of bacterial adherence to glutaraldehyde-fixed EC. After preincubation with the respective blood protein or proteins, the monolayers were washed with M199, incubated with radiolabeled bacteria for 1 h, washed three times with M 199, lysed, and counted for radioactivity as previously described.
All data were derived from analysis of samples performed in quadruplicate. Unless otherwise stated, the data presented represent a single experiment with an analysis performed on quadruplicate wells. The results of each study were repeated at least two times to confirm the validity ofthe data. The number ofadherent bacteria was derived from a standard curve of cpm plotted against CIFU for each bacterial strains tested. Within each set ofdata that compared variables, the experiment was performed concurrently from the same batch of bacterial cells grown on the same day. Because ofthe variability of results from individual EC cell lines, critical experiments with relevance to each other were accomplished with the same cell line from the same passage.
Preparation of affinity purified goat anti-human fibrinogen antibody. Goat anti-human fibrinogen antibody was prepared as previously described (28) . Briefly, 10 mg of human fibrinogen (Sigma Chemical Co.) dissolved in PBS was added to 1 g of glutardialdehyde activated beads (Boehringer Mannheim Biochemicals). After incubation overnight at 4VC, the beads were washed sequentially with 1.5% NaCl, 0.3 M ethanolamine, 0.9% NaCl, 0.5 M propionic acid, 0.9% NaCl, and PBS, as described (29) . Goat anti-human fibrinogen IgG (50 mg in 3 ml of PBS [Cappel Laboratories, Cochranville, PA]) was adsorbed to the fibrinogen-linked affinity column by rotating the mixture at 4VC overnight (8) . After washing the column extensively with PBS, adsorbed antibodies were eluted under acid conditions (pH 2.5), neutralized, and concentrated. The monospecifity of the affinity purified goat anti-human fibrinogen IgG was verified by an immunoblot using purified fibrinogen and plasma as antigens as previously described (28) . The protein concentration of the affinity-purified antibody was determined by the BCA protein assay reagent (Pierce Chemical Co., Rockford, IL).
Conjugation of affinity-purified goat anti-human fibrinogen antibody with alkaline phosphatase. Affinity-purified goat anti-human fibrinogen antibody prepared above was conjugated to alkaline phosphatase (Sigma Chemical Co.) as described by Voller et al. (30) .
Preparation ofafibrinogenemic plasma using affinity chromatography. Affinity-purified goat anti-human fibrinogen antibody (5 mg) was covalently attached to 1 mg of glutardialdehyde-activated beads as described above. 5 ml of heparinized plasma was allowed to rotate with the beads in a column (1.5 X 20 cm) at 4°C overnight followed by the collection of fibrinogen-deficient plasma in the fall through. After acid elution to remove adsorbed fibrinogen on the column (28), the fall through was reapplied to the same column. The procedure was repeated twice to assure complete removal offibrinogen from the plasma sample. The absence of fibrinogen in the sample was verified by a dot blot assay in which 25 ul ofthe fall through was applied to a nitrocellulose membrane in a dot blot apparatus (Bio-Rad Laboratories, Inc., Richmond, CA). After blocking the membrane with blocking buffer (Tris 0.01 M with 0.5 M NaCI and 0.5% Tween 20, pH 8.2) for 1 h at RT, alkaline phosphatase conjugate of the affinity-purified goat antihuman fibrinogen antibody diluted 1:1,000 in blocking buffer was incubated with the blot for 1 h followed by development with substrate as described by Blake et al. (27) . Dilutions ofplasma and purified fibrinogen serve as positive controls, whereas BSA was included as a negative control.
Determination ofthefibrinogen concentration in plasma. Fibrinogen concentration in plasma was determined by the modified thrombin time test (diagnostic kit 880, Sigma Chemical Co.) as described in the manufacturer insert.
Studies on the inhibition ofstaphylococcal adherence to EC with competitive assays. To evaluate the specificity of fibrinogen in mediating staphylococcal adherence to EC, adherence assays were performed with monolayers in microtiter wells that have been preincubated with 100 MAl of plasma diluted with an equal volume of M 199 followed by two briefrinses with M199. In preliminary studies, the effect ofstaphylococcal adherence to plasma-treated EC in the presence offibrinogencontaining media was assessed. Within a range of fibrinogen concentration tested (10 mg-iIMg/ml), bacterial clumping was found to occur and thus the direct influence offibrinogen in the medium on the inhibition of bacterial adherence to EC cannot be tested. To investigate the effect ofantibody in blocking bacterial adherence, the wells containing EC were allowed to incubate with bacterial cells to which 50 MUg ( [31] ), a platelet antigen which has been found to be on the surface ofEC in high concentration (Jaffe, E. A., unpublished observation), was used in place of goat anti-fibrinogen antibody to further define the specificity of fibrinogen in the mediation of staphylococcal adherence to EC. In other experiments, EC precoated with plasma were incubated with radiolabeled LM or DB cells to which various concentrations ofaffinitypurified goat anti-human fibrinogen antibody or nonimmune goat IgG had been added in a competitive assay. After a 1-h incubation period, EC were washed, lysed, and counted as described.
Assays ofstaphylococcal adherence to EC in thepresence ofafibrinogenemicplasma. To further confirm fibrinogen as an important mediator of staphylococcal adherence, glutaraldehyde-fixed EC were preincubated with 100 Ml ofeither plasma or afibrinogenemic plasma diluted with an equal volume of M 199 for 30 min followed by two rinses with M 199. In other assays, various concentrations offibrinogen were added to the afibrinogenemic plasma before preincubation with EC. After these incubations, labeled S. aureus cells were added to the monolayers as described. The monolayers were then washed, lysed, and counted. Detection offibrinogen on EC by immunofluorescence and ELISA.
To verify the presence of fibrinogen on EC, endothelial monolayers were fixed with 0.05% glutaraldehyde for 5 min in six-well tissue culture dishes. The monolayers were then incubated with plasma (1:1 dilution with M 199) or M 199 for 30 min followed by three washes with M199 with agitation for 5 min each. Fluorescein-conjugated F(ab)2 fragments of goat anti-human fibrinogen IgG (1:5 dilution in M199) (Cappel Laboratories) were then added and allowed to incubate with EC for another 30 min. After four additional washes with Ml99, the EC were examined by immunofluorescent microscopy as described (32) . As a control, EC were incubated with the fluorescein conjugate without prior treatment with plasma.
ELISA was also used to ascertain the presence of fibrinogen on EC after preincubation with plasma. EC in microtiter wells were fixed with 0.05% glutaraldehyde as described. After blocking the EC with ELISA blocking buffer (0.01 M Tris with 0.15 M NaCl and 0.1% BSA, pH 7.4) for 1 h, the monolayers were incubated with 100 Ml ofplasma in different dilutions at 370C for 45 min (1:200 to 1:12,800 in fourfold dilutions). Serum at 1:200 dilution or HSA (1 mg/ml) was used as controls. After two washes with M199, the wells were incubated with affinitypurified goat anti-human fibrinogen or goat anti-mouse IgG diluted 1:1,000 in blocking buffer for 3 h at 370C with shaking. After six washes with blocking buffer, rabbit anti-goat alkaline phosphatase diluted 1:2,000 was added and incubated at room temperature (RT) overnight.
The EC cells were again rinsed six times with blocking buffer. Developing substrate (p-nitrophenol) was added to the wells and the plate was read at 405, at timed intervals.
Visual confirmation ofbacterial adherence to EC. To visually confirm staphylococcal adherence to EC, endothelial monolayers were grown to confluence in 20 X 20-mm coverslips placed in six-well tissue culture dishes. After fixing the EC with 0.05% glutaraldehyde, the wells were incubated with 1 ml of either M199 or plasma (diluted with an equal volume of Ml99) for 30 min at RT with agitation followed by two washes with 1.5 ml ofM 199 each. S. aureus cells and the S. epidermidis control (1 ml volume) were added and further incubated for 1 h at RT with agitation. In some assays, 500 ,g of either affinity-purified 
Results
Staphylococcal adherence to EC. Two S. aureus strains, LM and DB, and a S. epidermidis control were used to examine the effect of the time of incubation on bacterial adherence to EC. In the presence of M 199 alone, prolonging the time of incubation had no effect on bacterial adherence among the bacterial species for up to 2 h (Fig. 1) . In contrast, preincubation of the monolayers in microtiter wells with plasma revealed a signifi- To further validate the adherence results with radiolabeled bacteria in microtiter wells, experiments were conducted to visually confirm bacterial adherence in a semiquantitative manner. Confluent endothelial monolayers on 20 X 20-mm coverslips fixed with glutaraldehyde were pretreated with plasma followed by incubation with LM cells as described. In some assays, various concentrations of goat anti-fibrinogen antibody were added to EC to block bacterial adherence (see result below). Aftergram stain, the average number ofbacteria per visual field on these coverslips was obtained by enumerat- ing the total number of microorganisms in 10 randomly selected visual fields. Results demonstrated good correlation between the number ofbacteria per visual field and cpm ofadherent bacteria obtained from the adherence assays in microtiter wells. The correlation coefficient between two variables in a number of experiments ranged from 0.87 to 0.99.
The role ofbloodproteins in the mediation ofadherence of S. aureus to EC. In an effort to identify the important plasma mediator or mediators of staphylococcal adherence to EC, different isolated plasma proteins were used to coat EC before the addition of radiolabeled bacteria. As displayed in Table I A, fibrinogen (1 mg/ml) in the presence of HSA, although less effective than that ofplasma, resulted in a threefold increase in bacterial adherence in comparison to the M199 control. In contrast, there was only a slight increase in adherence to EC with either fibronectin or vitronectin. Similarly, preincubating EC with HSA alone did not increase bacterial attachment. Results with serum (which contains IgG) differed between the two S. aureus strains because adherence with serum was higher with the protein A-containing strain DB than with LM, a protein A-deficient strain (22) . The small increase in adherence with serum on DB appeared to be mediated by protein A reacting with adsorbed IgG on EC because the enhancement effect with DB could be inhibited by adding soluble Cowan I protein A (Calbiochem-Behring Corp.) in the assay to compete with the bacteria for available binding sites on adsorbed IgG (data not shown). By comparison, none ofthese blood protein preparations had any effect on the binding of S. epidermidis to EC.
The effect of other blood proteins in conjunction with fibrinogen was also studied. Combinations of fibrinogen with Staphylococcal Adherence to Endothelial Cells 2239 To evaluate the effect offibrinogen concentrations on staphylococcal adherence to EC, the level offibrinogen in the plasma sample (diluted 1:1 with M 199) was first determined to be 1.55 mg/ml. Using a range of fibrinogen concentrations (0.1-2.0 mg/ml) diluted in M199, it was found that the number of S. aureus cells adhering to EC, although contingent upon the fibrinogen concentration, did not approach that of plasma (diluted 1:1) even at a high concentration offibrinogen (2 mg/ml) ( Fig. 2) . At 0.1 mg/ml, the number ofadherent bacteria per EC approached that of the Ml 99 control. On the other hand, serum (diluted 1:1) in combination with fibrinogen at 1.5 mg/ ml could promote staphylococcal adherence to a level comparable with that of the plasma sample for strain DB, whereas the effect on LM was less. Additional studies with fibrinogen (1.5 mg/ml) and serum heated at 56°C for 0.5 h to inactivate complements yielded similar results (data not shown).
Immunofluorescent microscopy was used to verify the presence of fibrinogen on plasma-treated EC. Bright immunofluorescence of plasma-treated EC was observed, whereas the control without prior plasma treatment exhibited no immunofluorescence (Fig. 3) on EC, a modified ELISA was performed using fixed EC as the solid phase support. Results indicated that the amount of fibrinogen adsorbed from plasma to EC was dependent on the dilution ofplasma (data not shown). Control wells using serum or HSA to coat the EC and nonimmune goat IgG as the control antibody did not reveal OD readings significantly above background.
Blocking adherence to EC. Inhibition experiments with antibodies were used to demonstrate the specificity of binding of S. aureus to adsorbed fibrinogen on EC. EC preincubated with plasma were allowed to incubate with tritiated S. aureus or S. epidermidis cells in microtiter wells in the presence of various antibodies for 1 h in a competitive assay. Results showed that neither antibodies to human fibronectin and vitronectin nor nonspecific polyclonal and monoclonal antibodies (IgG,) were able to block the attachment of S. aureus to EC (Table II A) . Likewise, a MAb directed against AG-1, a platelet antigen found on the surface ofEC in high concentration, did not block the adherence of S. aureus to EC (Table II B ). In contrast, affinity-purified goat anti-human fibrinogen blocked adher- Glutaraldehyde-treated EC in microtiter wells were preincubated with 100 Ml of plasma diluted with an equal volume of Ml99 as described. After washing the wells twice with M199, tritiated bacteria were mixed with the monolayer and futher incubated for 1 h at 370C with agitation. In some assays in A, various antibodies (a 25 Ml in volume) were mixed with bacteria (100 Ml) and added to the monolayer whereas M199 was added to the control well before bacterial incubation. In separate experiments (B), various antibodies (au 10 Ml) were mixed with bacteria (40 Ml) before they were added to the monolayer for further incubation. A smaller incubation volume was chosen for the latter experiments to conserve the amount of antibody employed while maintaining a reasonable concentration in the assay. After incubation, the monolayers were washed, lysed, and portions counted for radioactivity as described in the text. The amount of adherent bacteria was deduced from a standard curve of CFU vs. radioactive counts. Values are given in number of CFU bound per endothelial cell (mean±SEM, n = 4). * The reduction in CFU bound per endothelial cell was statistically significant for the tested strains (P < 0.04 in A and P < 0.03 in B by two-tail t test) when compared with non-treated controls. t Not statistically significant (t test) for both LM and DB strains when compared with nontreated controls. § Not statistically significant for the tested strain when compared with nontreated controls.
ence for both strains of S. aureus (Table II, A and B) . The reduction in adherence was 88 and 78% of controls for strains LM and DB, respectively, when 50 ,g of anti-fibrinogen antibody was used in the assay (Table II A) . Similarly, studies with EC grown on coverslips which were gram-stained after bacterial incubation (with or without antibody) also supported these results (Table III) . None of the antibodies had an effect on the adherence of S. epidermidis to EC (Table II) . This was also confirmed by gram-stained studies (Table III) . The blocking activity of the anti-fibrinogen antibody was dose dependent (Table IV) , whereas control goat IgG had no effect (Tables II   and IV) . Bacterial adherence with afibrinogenemic plasma. To further substantiate the role of fibrinogen as an important plasma mediator ofstaphylococcal adherence to EC, studies were done with fibrinogen-deficient plasma. Afibrinogenemic plasma was prepared from heparinized -plasma with an affinity column containing anti-fibrinogen antibody-linked beads. Dot blot showed that the afibrinogenemic plasma displayed no reaction with anti-human fibrinogen antibody, whereas plasma and purified fibrinogen (1 mg/ml) controls were reactive at 1:1,000 dilution. When EC were preincubated with afibrinogenemic plasma (diluted 1:1), bacterial adherence did not differ from that ofthe M 199 control (Fig. 4) . However, addition offibrinogen to afibrinogenemic plasma in the incubation medium was able to restore bacterial adherence to EC to a level approaching that of plasma in a concentration-dependent manner (Fig. 4) .
Discussion
It has been estimated that acute endocarditis involves normal heart valves in at least 50% of the cases (10, 11) , whereas the subacute form occurs most often in patients with underlying valvular abnormalities. Because of this difference in target tissue involvement, an investigation into the pathogenesis of acute endocarditis should focus on the interaction between the bacteria and undamaged endothelial surface. For this reason, we chose confluent monolayers of human endothelium in tis- Our study into staphylococcal attachment to cultured EC preincubated with various blood factors demonstrates that the preferential attachment of S. aureus to EC appears to be mediated by fibrinogen adsorbed from plasma onto the endothelial surface. In contrast, S. epidermidis, an organism generally not known to cause acute intravascular infection on native endothelium did not manifest binding to fibrinogen.
The attachment of S. aureus to fibrinogen bound on EC appeared to be specific because it could be blocked by goat anti-human fibrinogen antibody in a dose-dependent fashion, whereas nonimmune goat IgG, nonspecific mouse MAb, and antibodies to human vitronectin and fibronectin were not inhibitory (Tables II A and IV) . Whether blocking is due to steric hindrance or competitive binding by the antibody to the portion of the fibrinogen molecule where staphylococcus adheres cannot be absolutely determined by these studies. Nevertheless, the fact that a MAb directed against AG-1, a platelet antigen found on EC in abundance, did not block staphylococcal adherence to EC would seem to suggest specific binding between the bacteria and fibrinogen adsorbed onto the endothelial cell receptor (14) while minimizing the role of steric hindrance due to anti-fibrinogen antibody. Although our results provide strong evidence that fibrinogen is an important plasma mediator of staphylococcal adherence to EC, our data also suggested that the presence of fibrinogen is necessary but not the only requirement for the significant promotion of staphylococcal adherence to EC. This was supported by the finding that fibrinogen alone at serum concentration did not potentiate staphylococcal adherence to a degree that was comparable with that of plasma (Fig. 2) .
Previous in vitro studies have shown that S. aureus is more adherent than enteric gram-negative bacilli to the native endocardial surface (4, 5, 34) . However, these studies are largely accomplished in systems where the assays were performed either in the presence of serum or devoid of plasma factors altogether. More recently, several studies have implicated fibronectin and vitronectin in the mediation ofadherence ofgram-positive bacteria to EC. Immunoelectron microscopic studies by Vann et al. (35) suggests that fibronectin found in areas between S. aureus and cultured bovine endothelial cells might be involved in the adherence ofS. aureus, thus implicating a possible role for fibronectin in endocarditis. Valentin-Weigand et al. have also shown that vitronectin may play a mediatory role in the adherence of streptococci to cultured human endothelial cells (36) . In distinction to these studies, our results have minimized the role played by vitronectin and fibroctin, whereas the importance of fibrinogen adsorbed from plasma in the mediation of staphylococcal adherence to EC was emphasized. This discrepancy may have been due to experimental design in that we have used plasma and fibrinogen at a level approaching physiologic concentrations in our adherence assays. In addition, we have also allowed for the competition among various plasma components in their binding to EC before bacterial attachment. Further, our bacterial cells were filtered, rather than sonicated, to disperse bacterial aggregates before the adherence assay. This approach was undertaken to avoid any loss in bacterial fibrinogen binding capacity as a result of sonication (37) . An alternative explanation for the discrepancy in results may be due to differences in receptor expression for fibrinogen, vitronectin, and fibronectin between strains used in different studies.
Using a technique based on the pH-dependent affinity of iminobiotin for streptavidin, Tompkins and colleagues (38) have identified and isolated a 50-kD endothelial cell membrane protein that appears to bind to S. aureus in vitro. Ofnote is the finding in their study that preincubation ofbacteria with a physiological concentration of fibrinogen in Ml 99 did not appear to interfere with the binding of staphylococci to confluent human endothelial cell monolayers. Because of significant differences in the methodology used for the adherence assay, a direct comparison ofthe data cannot be made between their studies and ours. For instance, in this study fibrinogen was used to preincubate EC, whereas fibrinogen was allowed to coat the bacteria before incubation with EC in the other study. Nevertheless, preincubation of the endothelium with fibrinogen alone in our study results only in a mild increase in staphylococcal adherence (Table I ) when compared with that of plasma. Thus, despite assay differences, the similarity in trend is apparent between the results of these two studies.
Recently, the fibrinogen binding component on S. aureus has been isolated and is reported to be a protein complexed with carbohydrate (mol wt 420 kD) (16) . However, the molecular size of the uncomplexed form of the protein was not determined. Purification studies by Usui et al. (17) reported the fibrinogen binding component to be proteins with molecular masses of 62, 61, and 59 kD. Similarly, the results of our previous study also confirm the fact that the fibrinogen receptor on the staphylococcal surface is likely to be a protein (28) . Its relative resistance to trypsin and sensitivity to proteinase K also suggest that it may exist as a compact structure in which the arginine and lysine residues present in the molecule (16) are not exposed.
Although the fibrinogen binding receptor on S. aureus, also called clumping factor, has been suggested as a virulence factor on the basis of more severe infection in clumping factor positive strains (40) , the mediatory role of this protein in endoscular invasion by S. aureus is not well defined. The current study has provided strong evidence that the mediation ofstaphylococcal adherence to EC during transient bacteremia (e.g., catheters) probably occurs through a bridging molecule such as fibrinogen that is adsorbed on EC through both specific (14, 39) and nonspecific mechanisms (12, 41) . Because adherence is a prerequisite to endovascular invasion, the results ofour study strongly implicate the fibrinogen binding receptor ofS. aureus to be an important mediator of staphylococcal adherence to endothelium. With the knowledge that fibrinogen is an acute phase reactant that is frequently elevated in critically ill patients (42) , increased plasma fibrinogen levels may potentially increase the adsorption of this molecule onto the endothelial surface in susceptible patients, thereby allowing more S. aureus cells to adhere through the fibrinogen receptor.
In previous studies examining the interaction between fibrinogen and cultured EC (39, 43) , it was shown that the association of fibrinogen with EC was generally rapid and reached a plateau within 20 min. The binding affinity offibrinogen to EC in monolayers was moderate, yielding a value of 1.5 X 10-6 M (40). The minimal fibrinogen concentration required to promote EC binding to a fibrinogen-covered substrate was approximately one-tenth that of plasma (i.e., between 0.2 and 0.4 mg/ ml) (44) . This is in agreement with our result on the amount of fibrinogen necessary in the preincubation medium to promote staphylococcal attachment to EC (Fig. 2) .
In addition to fibrinogen, our data also indicate that other plasma factor(s) might play mediatory roles in the adherence of S. aureus to EC. This hypothesis is supported by the observation that preincubation with serum and fibrinogen (Table I B) or afibrinogenemic plasma in the presence of fibrinogen (Fig.  4 ) enhance staphylococcal adherence to a level comparable with that of plasma and that this level of adherence is more than that obtained with fibrinogen alone. Our result would be consistent with a model in which the binding of fibrinogen to EC would increase in the presence ofanother yet unknown, but possibly activated, plasma factor(s). This model would explain the discrepancy in bacterial adherence between the mild promotional role of fibrinogen alone and the effective blocking of staphylococcal adherence to EC in the presence ofanti-human fibrinogen antibody.
The findings in this study may be particularly relevant to acute endocarditis and other intravascular infections in patients who develop transient staphylococcal bacteremia (e.g., from catheters). One would expect in this situation that the endothelium would be "stimulated" before the attachment of the staphylococci. The requirement of a second blood factor, possibly activated during inflammation, for the promotion of staphylococcal adherence to EC via enhanced fibrinogen binding is a hypothesis that is concordant with the results of this investigation. Our findings also reveal that the contributory plasma factor(s) is unlikely to be vitronectin, fibronectin, immunoglobulin, or serum complement (Tables I and II) . Whether other blood coagulation factors play a role in the promotion of fibrinogen binding to EC is not determined in these studies. Nevertheless, it is tempting to speculate that fibrinogen binding to endothelium during acute inflammation (e.g., during transient bacteremia) plays a role in the potentiation of endothelial invasion for staphylococci.
